Retrograde Intrarenal Surgery versus Percutaneous Lithotripsy to Treat Renal Stones 2-3 cm in Diameter

Zengın, Kürşad; Tanık, Serhat; Karakoyunlu, Nihat; Şener, Nevzat Can; Albayrak, Sebahattın; Tuygun, Can; Bakırtaş, Hasan; İmamoğlu, Abdurrahim; Gürdal, Mesut

doi:10.1155/2015/914231

Cited by 39 publications

(41 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The summarized flow chart for treatment algorithm is shown in Figure 3. 166,[174][175][176][177][178][179][180][181]184,185,188,189,[191][192][193][194][195][196][197][198][199][200][201][202][203][204][205][206]. What is an algorithm for treatment of adult patients with ureteral stones?…”

Section: Commentarymentioning

confidence: 99%

The Urological Association of Asia clinical guideline for urinary stone disease

et al. 2019

View full text Add to dashboard Cite

The Urological Association of Asia, consisting of 25 member associations and one affiliated member since its foundation in 1990, has planned to develop Asian guidelines for all urological fields. The field of stone diseases is the third of its guideline projects. Because of the different climates, and social, economic and ethnic environments, the clinical practice for urinary stone diseases widely varies among the Asian countries. The committee members of the Urological Association of Asia on the clinical guidelines for urinary stone disease carried out a surveillance study to better understand the diversity of the treatment strategy among different regions and subsequent systematic literature review through PubMed and MEDLINE database between 1966 and 2017. Levels of evidence and grades of recommendation for each management were decided according to the relevant strategy. Each clinical question and answer were thoroughly reviewed and discussed by all committee members and their colleagues, with suggestions from expert representatives of the American Urological Association and European Association of Urology. However, we focused on the pragmatic care of patients and our own evidence throughout Asia, which included recent surgical trends, such as miniaturized percutaneous nephrolithotomy and endoscopic combined intrarenal surgery. This guideline covers all fields of stone diseases, from etiology to recurrence prevention. Here, we present a short summary of the first version of the guideline – consisting 43 clinical questions – and overview its key practical issues.

show abstract

Section: Commentarymentioning

confidence: 99%

The Urological Association of Asia clinical guideline for urinary stone disease

et al. 2019

View full text Add to dashboard Cite

show abstract

“…A more recent study including 30 patients with renal pelvic stones over 2 cm reported an SFR of 89%. Zengin et al also evaluated the outcomes of PCNL in patients having 2-3 cm renal pelvic stones and reported a success rate of 95.5% [15]. Akman et al also investigated the success rates of PCNL in patients who had renal stones 2-4 cm in diameter and reported an SFR of 91.2%, respectively [16].…”

Section: Discussionmentioning

confidence: 99%

Comparison of ureteroscopy and percutaneous nephrolithotomy for renal pelvic stones over 2 cm

Küçükdurmaz¹

2018

Ann Clin Anal Med

View full text Add to dashboard Cite

Aim: Advances in the technology of ureteroscopes and lithotriptors have led to the implementation of retrograde intrarenal surgery (RIRS) in the treatment of renal Stones. This study aimed to compare the outcomes and complications of semirigid ureterorenoscopy (s-URS) and percutaneous nephrolithotomy (PCNL) for the treatment of renal pelvic stones larger than 2 cm, retrospectively. Material and Method: Between January 2014 and July 2016, 90 patients with single renal pelvic stones of more than 2 cm were treated by PCNL (group 1) or s-URS (group 2). Group 1 had 44; group 2 had 46 patients. Demographic features of patients such as age, gender, body mass index (BMI) as well as stone size were compared. Perioperative course and postoperative outcomes such as stone-free and complication rates were also evaluated. Patients assessed by plain abdominal radiography 24 hours after surgery and non-contrast computed tomography at 3rd months, postoperatively. Clinical success was defined as stone-free status. Results: Mean ages of patients in group 1 and 2 were 40.29±19.78 and 38.41±23.26 year, respectively (p=0.681). Two groups were comparable in terms of gender, BMI, grade of hydronephrosis. Mean stone sizes were also similar. The mean operation, fluoroscopy and hospitalization times were shorter in group 2. After first sessions, mean stone-free rates for PCNL and s-URS were 81.8% and 60.8%, respectively (p=0.037). In the s-URS group,11 patients underwent f-URS due to stone migration into lower calix, and 7 of them became stone-free after those procedures. At 3rd months follow-up, those rates were determined as 84.1% and 76%, respectively. Discussion: Although s-URS is not superior to PCNL in the treatment of large renal pelvic stones, it can be used to reach renal pelvis and fragment those stones in selected cases.

show abstract

“…RIRS can be an effective treatment alternative to PNL [19,20]. As RIRS affords a comparable success rate to PNL and causes fewer risks of complications it seems to be a promising alternative to PNL when larger stones are to be treated [21,22].…”

Section: Pcnl Which Has Been Established In the 1970smentioning

confidence: 99%

Thermobalancing Therapy® should be the First-Line Treatment for Kidney Stones and Benign Prostatic Hyperplasia, Discussions at the Medical Conferences

2017

ARC Journal of Urology

View full text Add to dashboard Cite

Background: The prevalence of kidney stone disease is increasing around the world, notonly in men but in women. All surgical removals of kidney stones, such as extracorporeal shock wave lithotripsy (ESWL) and percutaneous nephrolithotomy (PCNL) have serious side effects and complication. There are parallel undesirable problems in men after conventional treatments of benign prostatic hyperplasia (BPH) with medications and surgery. At the same time Thermobalancing therapy (TT) enabled by Dr Allen's therapeutic device (DATD) has demonstrated positive impact on chronic internal diseases. Therefore, these issues were discussed at the Nephrology Conference in Spain and at the Global Health Conference in China, in October-November 2017.The purpose of this review is to talk about the key points of discussions at these conferences and proposals for the future. Methods and Results: The case study on TT with DATD in patient with kidney stones; and the outcomes from the clinical trial on TT in 124 men with BPH, before and after 6-month period they used DATD. TT with DATD dissolved kidney stones in a woman; reduced Prostate Volume (PV mL) (P<0.001) and diminished urinary symptoms (P<0.001) in men with BPH. Conclusion: The implementations of TT with DATD for the treatment of kidney stone disease were the key note discussions at the Medical Conferences. For over 7 years TT with DATD has been given for hundreds of sufferers with kidney stone disease and thousands with BPH. The results of the case study and clinical trial recommend TT with DATD for kidney stone disease and BPH as the first line treatment. This will help patients to avoid BPH medication and surgical procedures, including ESWL and PCNL, with their risks and complications. Furthermore, DATD should be introduced into the Guidelines for Medical Specialist for men with BPH and people with kidneys stones disease

show abstract

Retrograde Intrarenal Surgery versus Percutaneous Lithotripsy to Treat Renal Stones 2-3 cm in Diameter

Cited by 39 publications

References 17 publications

The Urological Association of Asia clinical guideline for urinary stone disease

The Urological Association of Asia clinical guideline for urinary stone disease

Comparison of ureteroscopy and percutaneous nephrolithotomy for renal pelvic stones over 2 cm

Thermobalancing Therapy® should be the First-Line Treatment for Kidney Stones and Benign Prostatic Hyperplasia, Discussions at the Medical Conferences

Contact Info

Product

Resources

About